The Claim
Computational modeling identifies a previously unreported target site that emerges during the final step of myostatin activation, and targeting this site with small molecules inhibits myostatin activity and promotes muscle growth.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A computational model has identified a new site involved in the final step of myostatin activation; blocking this site with small molecules reduces myostatin activity and increases muscle growth.
See the scientific wording
Computational modeling identifies a previously unreported target site emerging during the final step of myostatin activation, suggesting that targeting this site with small molecules could offer a new strategy for preventing myostatin activity and promoting muscle growth.
A hidden structure appears briefly when the muscle-limiting protein is about to become active. A drug that binds to this structure stops the protein from fully activating. Without the active protein, muscles are no longer suppressed and grow larger.
What the research says
1 studyStudy: Exploring the Myostatin Activation Pathway: A Promising Target for Treating Muscle Atrophy
Computer simulations found a hidden part of a muscle-limiting protein that only shows up right before it turns on. Blocking this part with a drug could stop the protein from working, helping muscles grow bigger.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.